Dr. Adam Marsh of Genome Profiling, LLC to Present at the Cancer Diagnostics Conference in San Francisco on November 16, 2015

NEWARK, DE - Nov 12, 2015 - Genome Profiling, LLP (GenPro), an epigenetic biomarker discovery company to clinical research institutions, biopharma and diagnostics companies, announced that Adam Marsh, Ph

Scientists Publish Unique Genomic Discoveries with Single Molecule, Real-Time Sequencing

ST. LOUIS, MO, UNITED STATES - Nov 11, 2015 - A new paper released in Nature today reported the virtually complete draft genome of Oropetium thomaeum, a grass species that can regrow after exposed to extreme drought when water becomes available

NewLeaf Symbiotics Receives Key US Production Patent

ST. LOUIS, UNITED STATES - Nov 11, 2015 - The US Patent and Trademark Office has granted NewLeaf Symbiotics US Patent No. 9,181,541 for its Microbial Fermentation technology

University of Chicago Graham School Launches Master of Science Degree in Biomedical Informatics

CHICAGO, IL - Nov 5, 2015 - Biomedical informatics, one of the world’s fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies

Aridhia Announces Northern Ireland Based Alzheimer's Research Collaboration to Benefit from AnalytiXagility Workspace

EDINBURGH, UK - Nov 5, 2015 - Aridhia, the Edinburgh based clinical informatics company, announced today that their AnalytiXagility data platform has been chosen to underpin a three year research programme that was awarded Innovate UK funding via the Neurodegenerative Diseases: Business Models and Big Data competition, following a joint bid by three of Northern Ireland’s leading organisations

Congenica and GenomOncology announce collaborative agreement at AMP

CAMBRIDGE, UK - Nov 5, 2015 - Congenica, leader in genomic interpretation and diagnostics in rare genetic disease, and GenomOncology, specialists in precision medicine technology in the field of oncology, are announcing a pilot collaboration that will support the commercialisation of each other’s products in the USA and UK respectively and offer strategic partners a scalable data platform

MAVERIX ANNOUNCES “MAGIX” GRANT PROGRAM TO ACCELERATE GENE EXPRESSION RESEARCH USING RNA-SEQ

SAN MATEO - Nov 3, 2015 - Maverix Biomics, Inc., a leading genomic analysis software company, today announced a grant program designed to foster the rapid adoption and acceleration of gene expression research using Next Generation Sequencing (NGS)

Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project

CAMBRIDGE, MA - Nov 3, 2015 -  

• The San Antonio 1000 Cancer Genome Project is collecting tumor and normal patient samples in the ten most common cancers from across a single metropolitan area
• WuXi NextCODE's CLIA laboratory will have sequenced the majority by year endx

CCDC Blind Test Showcases Major Advance in Crystal Structure Prediction Methods

CAMBRIDGE, UK - Nov 3, 2015 - The Cambridge Crystallographic Data Centre (CCDC) announces that the results of its 6th blind test of crystal structure prediction methods demonstrate significant advancement in crystal structure prediction methods in comparison with previous testsx

Tute Genomics Acquires Knome

PROVO, UT - Nov 2, 2015 -   Tute Genomics, the leader in clinical sequencing informatics, today announced the acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commercial advancements in modern human genetics

FDA Equips its Pharmacometrics Teams with Certara’s Phoenix Software

PRINCETON, NJ, USA - Nov 2, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the United States Food and Drug Administration (FDA) has outfitted its pharmacometrics teams with Certara’s Phoenix® software

Creative Bioarray Introduces Cryopreserved Mesenteric Cells for Biologists

NEW YORK, NY - Oct 30, 2015 - Creative Bioarray, an innovative biotechnology company who produces the world's most comprehensive list of research-use cells, including tumor cells, primary cells, stem cells and transformed cells, etc, recently announced its new cryopreserved mesenteric cells for researchers, aiming to provide customers more tools for scientific study

BC Platforms to Collaborate with Helsinki University Hospital to Apply its Proprietary Genomics Management Platform to Provide Clinical Benefits for Cancer Patients

HELSINKI, FINLAND - Oct 26, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that it has signed a partnership agreement with Helsinki University Hospital to use its genomic management platform to integrate, analyze and interpret their extensive clinical and genealogy data with next-generation sequencing data to provide innovative, personalized treatment options for breast cancer patients at the hospital

CSM Held Successful Grand Opening of New Clinical Trial Supply Facility in Malvern with Elected Officials

MALVERN, PA - Oct 21, 2015 - CSM welcomed over 100 attendees to celebrate the opening of its second facility in the Great Valley Corporate Center of Malvern, Pennsylvania

Cenduit to Lead Panel at 2015 Interactive Response Technologies in Clinical Trials Forum in Philadelphia

DURHAM, NC, UNITED STATES - Oct 20, 2015 - Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world by leading a panel at CBI’s 2015 Interactive Response Technologies in Clinical Trials Forum

Japan’s Agency for Medical Research and Development, AMED, Selects Certara’s Phoenix WinNonlin Software to Assess New Drug Candidates

PRINCETON, NJ - Oct 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Japan’s new Agency for Medical Research and Development (AMED) has selected Certara’s Phoenix® WinNonlin® software for pharmacokinetic/pharmacodynamic (PK/PD) modeling and non-compartmental analysis of new drug candidates

SyMyco Announces Expansion in St. Louis

ST. LOUIS, MO, UNITED STATES - Oct 19, 2015 - Today, SyMyco, a joint venture between Symbiotic Sciences based in New Delhi, India and Mycorrhizal Applications (MA), based in Grants Pass, OR, announced it is expanding its U

Certara Joins EU-ToxRisk – An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

PRINCETON, NJ - Oct 12, 2015 - An international consortium of 39 partner organizations will be funded by the European Commission to work on the integration of new concepts for regulatory chemical safety assessment

Drug Development is More than Life Science

BERLIN, GERMANY - Oct 12, 2015 - Dr. Anna Baran is Chief Medical Officer at KCR and in this strategic role she has developed a complex viewpoint on the challenges her position entails for a CROx

City of Hope Turns to PFS Clinical to Mitigate Regulatory and Financial Risk with Clinical Research Coverage Analysis and Budget Standardization

MIDDLETON, WI - Oct 7, 2015 - PFS Clinical, which offers turnkey administrative solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by City of Hope to provide Coverage Analysis (CA) to ensure its clinical research trials remain compliant with complex Medicare billing regulations